Zhejiang Shengda Bio-Pharm Co., Ltd. (SHA:603079)

SHA:603079 Revenue

Zhejiang Shengda Bio-Pharm had revenue of 189.22M CNY in the quarter ending March 31, 2026, a decrease of -13.41%. This brings the company's revenue in the last twelve months to 830.53M, down -1.81% year-over-year. In the year 2025, Zhejiang Shengda Bio-Pharm had annual revenue of 844.54M with 2.07% growth.

• Revenue (ttm): 830.53M
• Revenue Growth: -1.81%
• P/S Ratio: 2.90
• Revenue / Employee: 766.88K
• Employees: 1,035
• Market Cap: 2.41B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	844.54M	17.13M	2.07%
Dec 31, 2024	827.40M	100.00M	13.75%
Dec 31, 2023	727.41M	-10.61M	-1.44%
Dec 31, 2022	738.02M	-51.71M	-6.55%
Dec 31, 2021	789.73M	-77.58M	-8.95%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 8, 2026

Data Sources Report a data error